Cancer

Roche Gains FDA Approval for Expanded HER2 Diagnostic Test Indications

The test can now be used to identify HER2-positive metastatic breast cancer patients that could be eligible for Enhertu.

Cancer

New Somatic Cancer Reference Standards Launched to Monitor Diagnostic Assay Accuracy

The standards developed through a public-private partnership contain seven oncogenic mutations selected for clinical significance.

Cancer

BD HPV Assay Receives WHO Prequalification for Global Cervical Cancer Screening

The BD Onclarity HPV Assay detects 14 high-risk HPV types and supports self-collection.

Breath Test Technology Shows Promise for Early Lung Cancer Detection

Nov 7, 2025 | Lung Cancer

University of Texas at Dallas researchers combine electrochemical biosensors with AI to identify volatile organic compounds linked to thoracic cancers.

Blood Test Shows Superior Sensitivity for Early-Stage Liver Cancer Detection

Nov 7, 2025 | Cancer

Oncoguard Liver test demonstrates seven times greater sensitivity for very early-stage hepatocellular carcinoma compared to ultrasound surveillance.

Watchmaker Genomics Launches New Tech Enabling Simultaneous Detection of Methylation and Genetic Variants

Nov 6, 2025 | Cancer

TAPS+ chemistry preserves DNA integrity in challenging samples including FFPE tissue and circulating tumor DNA.

UC San Diego Health Now Offering Blood Test for Testicular Cancer

Nov 5, 2025 | Cancer

The test measures microRNA-371a-3P biomarker and can guide treatment decisions while reducing need for some CT scans during surveillance.

Blood Test Shows High Accuracy for Early Ovarian Cancer Detection

Oct 31, 2025 | Cancer

A new study demonstrates the capability of a blood test in detecting ovarian cancer up to three years prior to diagnosis in prospectively collected samples.

Blood Test Shows Promise for Tailoring Colon Cancer Chemotherapy

Oct 30, 2025 | Colorectal

Circulating tumor DNA testing can identify stage 3 patients who may safely receive reduced treatment intensity, international study finds.

Breaking Down Barriers to Cervical Cancer Screening Compliance by Introducing Self-Collection

Oct 30, 2025 | Cervical (HPV)

Self-collection for HPV and other infections offers a more convenient, private way to complete recommended screenings—helping reach women who might otherwise delay or skip care.

Study Validating Esophageal Cancer Test Accepted by Gastroenterology Journal

Oct 27, 2025 | Cancer

The mass spectrometry-based assay achieved 100% sensitivity in detecting patients who later progressed to cancer in a blinded cohort study.

Large Melanoma Trial Validates Gene Expression Test’s Predictive Accuracy

Oct 24, 2025 | Melanoma

A study of nearly 1,800 patients shows a threefold difference in sentinel node metastasis rates between high-risk and low-risk groups.

Biodesix Expands Bio-Rad Partnership for Droplet Digital PCR Assay Development

Oct 24, 2025 | Breast

The agreement focuses on clinical validation of ESR1 mutation detection assay for advanced breast cancer testing using ddPCR technology.

Multi-Cancer Blood Test Shows Seven-Fold Increase in Detection When Added to Standard Screening

Oct 24, 2025 | Cancer

PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.